Smart home tech could help lung patients breathe easier at home

NCT ID NCT06601790

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests a smart home system for people with interstitial lung disease, a condition that makes breathing difficult. Participants use home devices to track their health and do exercises, with the goal of improving symptoms and reducing hospital visits. The study compares those who start the system right away to those who wait three months, measuring changes in breathing, mood, and overall well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Smart Homespital system (behavioral intervention with home monitoring and exercise)
What this could lead to
If effective, this system could help people with interstitial lung disease manage their condition from home, potentially reducing hospital stays and improving quality of life.
What could go wrong
This is a small, early-stage trial with 83 participants, so results may not apply to everyone. The system relies on patients using the equipment correctly, and it may not work for those with severe limitations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Division of Pulmonary and Critical Care Medicine

    Seoul, 03722, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.